Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NEUROPROTECTION”

337 trials

Showing 20 of 337 results

Post-approval studies (Phase 4)Study completedNCT02096068
What this trial is testing

Neuroprotection With Dexmedetomidine in Patients Undergoing Elective Cardiac or Abdominal Surgery (Neuprodex)

Who this might be right for
DeliriumPostoperative Cognitive Deficit (POCD)
Claudia Spies 78
Large-scale testing (Phase 3)Study completedNCT06431113
What this trial is testing

Effect of Fixed Combination Citicoline Homotaurine and Pyrroloquinoline Quinone on Pattern-electroretinogram in Glaucoma

Who this might be right for
GlaucomaNeuroprotection
Fondazione IRCCS Policlinico San Matteo di Pavia 40
Testing effectiveness (Phase 2)Study completedNCT02071394
What this trial is testing

Xenon and Cooling Therapy in Babies at High Risk of Brain Injury Following Poor Condition at Birth

Who this might be right for
Hypoxic Ischaemic Encephalopathy
University Hospitals Bristol and Weston NHS Foundation Trust 50
Large-scale testing (Phase 3)Looking for participantsNCT04217421
What this trial is testing

Cerebrum and Cardiac Protection With Allopurinol in Neonates With Critical Congenital Heart Disease Requiring Cardiac Surgery With Cardiopulmonary Bypass

Who this might be right for
Congenital Heart Disease in ChildrenNeuroprotection
dr. M.J.N.L. Benders 236
Testing effectiveness (Phase 2)Study completedNCT01502046
What this trial is testing

Neuroprotection by Cannabinoids in Huntington's Disease

Who this might be right for
Huntington's Disease
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 25
Large-scale testing (Phase 3)Study completedNCT01378273
What this trial is testing

Preterm Erythropoietin Neuroprotection Trial (PENUT Trial)

Who this might be right for
Extreme Prematurity
University of Washington 941
Large-scale testing (Phase 3)Looking for participantsNCT07338175
What this trial is testing

Efficacy and Safety of Minocycline in Acute Spontaneous Intracerebral Hemorrhage

Who this might be right for
Intracerebral Hemorrhage
Beijing Tiantan Hospital 1,192
Not applicableUnknownNCT03818451
What this trial is testing

Co-ultra PEALut Enhances Neuronal Recovery Following Moderate Traumatic Brain Injury

Who this might be right for
Traumatic Brain Injury
University of Messina 60
Testing effectiveness (Phase 2)Looking for participantsNCT06434571
What this trial is testing

Comparing Telehealth-Delivered CBT-I to Web-Based CBT-I to Enhance Sleep, Reduce Fatigue, and Promote Neuroprotection

Who this might be right for
Multiple SclerosisInsomnia
University of Kansas Medical Center 90
Early research (Phase 1)Looking for participantsNCT05426681
What this trial is testing

Spinal Cord Injury Neuroprotection With Glyburide

Who this might be right for
Acute Spinal Cord Injury
Francis Farhadi 12
Not applicableStudy completedNCT05253534
What this trial is testing

GlaucoT Glaucoma Treatment Glasses in the Treatment of Primary Open-Angle Glaucoma

Who this might be right for
Primary Open-Angle Glaucoma
Glaucot Teknoloji Anonim Sirketi 15
Early research (Phase 1)Study completedNCT02235558
What this trial is testing

Superselective Administration of VErapamil During Recanalization in Acute Ischemic Stroke

Who this might be right for
Ischemic Stroke
Justin Fraser 11
Not applicableUnknownNCT05142085
What this trial is testing

Efficacy of Nano-PSO in Parkinson's Disease.

Who this might be right for
Parkinson Disease
Distribuidora Biolife SA de CV 170
Testing effectiveness (Phase 2)WithdrawnNCT04880577
What this trial is testing

Tenofovir Alafenamide for Treatment of Symptoms and Neuroprotection in Relapsing Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingFatigue
Massachusetts General Hospital
Testing effectiveness (Phase 2)Study completedNCT04681651
What this trial is testing

Normobaric Hyperoxia Combined With Endovascular Treatment in Acute Ischemic Stroke (OPENS-2)

Who this might be right for
Stroke, AcuteNeuroprotection
Capital Medical University 282
Not applicableLooking for participantsNCT06992115
What this trial is testing

The MIND Diet for Persons With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Icahn School of Medicine at Mount Sinai 100
Early research (Phase 1)WithdrawnNCT02823106
What this trial is testing

Superselective Citicoline and Verapamil for Ischemic Neuroprotection and Greater Effective Response

Who this might be right for
Ischemic Stroke
Justin Fraser
Testing effectiveness (Phase 2)UnknownNCT02258204
What this trial is testing

Ketamine for Thrombolysis in Acute Ischemic Stroke

Who this might be right for
Stroke
University Hospital, Caen 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT07504198
What this trial is testing

Neuroprotection of Memantine and Rosuvastatin

Who this might be right for
Peripheral Nerve Disease
Tanta University 46
Post-approval studies (Phase 4)WithdrawnNCT01546896
What this trial is testing

Effects of Buspar on Depressive Symptom Improvement and Neuroprotection in Patients With Anxiety Disorder

Who this might be right for
Anxiety Disorder
Seoul National University Hospital
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation